Skip to main content
SpringerLink
Log in

Interpreting randomised trials evaluating newer agents or interferon in multiple sclerosis

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Del Santo F, Maratea D, Fadda V, Trippoli S, Messori A (2011) Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis. Eur J Clin Pharmacol. doi:10.1007/s00228-011-1141-1

  2. Biondi-Zoccai GG, Abbate A, Agostoni P, Testa L, Burzotta F, Lotrionte M, Trani C, Biasucci LM (2005) Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregression. Am Heart J 149(3):504–511

    Article  PubMed  Google Scholar 

  3. Messori A, Fadda V, Maratea D, Trippoli S. Temporal trends of mortality in low-risk patients receiving statins for primary prevention (Rapid Response). eBMJ, 1 Feb 2012. Available at: http://www.bmj.com/content/344/bmj.d7809?tab=responses

  4. Walter S (2000) Choice of effect measure for epidemiological data. J Clin Epidemiol 53(9):931–939

    Article  PubMed  CAS  Google Scholar 

  5. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16. doi:10.1186/1745-6215-8-16

    Article  PubMed  Google Scholar 

  6. Guo S, Bozkaya D, Ward A, O'Brien JA, Ishak K, Bennett R, Al-Sabbagh A, Meletiche DM (2009) Treating relapsing multiple sclerosis with subcutaneous versus intramuscular interferon-beta-1a: modelling the clinical and economic implications. PharmacoEconomics 27(1):39–53

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratorio SIFO di Farmacoeconomia, Area Vasta Centro Toscana, ESTAV, 59100, Prato, Italy

    Andrea Messori, Fabiola Del Santo, Dario Maratea, Valeria Fadda & Sabrina Trippoli

  2. Laboratorio SIFO di Farmacoeconomia, Area Vasta Centro Toscana, Regional Health System, Via Guimaraes 9-11, 59100, Prato, Italy

    Andrea Messori

Authors
  1. Andrea Messori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabiola Del Santo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dario Maratea
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Valeria Fadda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sabrina Trippoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Messori.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Messori, A., Del Santo, F., Maratea, D. et al. Interpreting randomised trials evaluating newer agents or interferon in multiple sclerosis. Eur J Clin Pharmacol 68, 1225–1226 (2012). https://doi.org/10.1007/s00228-012-1247-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-012-1247-0

Keywords

Search

Navigation